受强制性开放获取政策约束的文章 - Keith Stockerl-Goldstein了解详情
无法在其他位置公开访问的文章：2 篇
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell …
SW Choi, T Braun, L Chang, JLM Ferrara, A Pawarode, JM Magenau, ...
The lancet oncology 15 (1), 87-95, 2014
强制性开放获取政策： US National Institutes of Health
Venous thromboembolism risk in patients with newly diagnosed multiple myeloma treated with carfilzomib or bortezomib in combination with lenalidomide and dexamethasone
AJ Loncharich, MA Fiala, MJ Slade, A Vickroy, M Kavanaugh, C Wilson, ...
Clinical Lymphoma Myeloma and Leukemia 23 (11), 825-828, 2023
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：78 篇
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
强制性开放获取政策： US National Institutes of Health, Fonds de recherche du Québec - Santé
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ...
Cancer cell 25 (1), 91-101, 2014
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
强制性开放获取政策： US National Institutes of Health
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
AJ Jakubowiak, D Dytfeld, KA Griffith, D Lebovic, DH Vesole, S Jagannath, ...
Blood, The Journal of the American Society of Hematology 120 (9), 1801-1809, 2012
强制性开放获取政策： US National Institutes of Health
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
GL Uy, MP Rettig, IH Motabi, K McFarland, KM Trinkaus, LM Hladnik, ...
Blood, The Journal of the American Society of Hematology 119 (17), 3917-3924, 2012
强制性开放获取政策： US National Institutes of Health
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
强制性开放获取政策： US National Institutes of Health, Fonds de recherche du Québec - Santé
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
强制性开放获取政策： US National Institutes of Health, US Assistant Secretary for Preparedness …
Maintenance therapy with decitabine after allogeneic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
I Pusic, J Choi, MA Fiala, F Gao, M Holt, AF Cashen, R Vij, CN Abboud, ...
Biology of Blood and Marrow Transplantation 21 (10), 1761-1769, 2015
强制性开放获取政策： US National Institutes of Health
Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience
AC Wolff, AL Blackford, K Visvanathan, HS Rugo, B Moy, LJ Goldstein, ...
Journal of clinical oncology 33 (4), 340-348, 2015
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
TA Fehniger, GL Uy, K Trinkaus, AD Nelson, J Demland, CN Abboud, ...
Blood, The Journal of the American Society of Hematology 117 (6), 1828-1833, 2011
强制性开放获取政策： US National Institutes of Health
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ...
Blood advances 3 (12), 1826-1836, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Patient-Centered …
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation
JP Smeltzer, AF Cashen, Q Zhang, A Homb, F Dehdashti, CN Abboud, ...
Biology of Blood and Marrow Transplantation 17 (11), 1646-1652, 2011
强制性开放获取政策： US National Institutes of Health
Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia
MM Berrien-Elliott, AF Cashen, CC Cubitt, CC Neal, P Wong, JA Wagner, ...
Cancer discovery 10 (12), 1854-1871, 2020
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sezary syndrome
PA Wu, YH Kim, PW Lavori, RT Hoppe, KE Stockerl-Goldstein
Biology of Blood and Marrow Transplantation 15 (8), 982-990, 2009
强制性开放获取政策： US National Institutes of Health
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow …
P Armand, HT Kim, MJ Zhang, WS Perez, PS Dal Cin, TR Klumpp, ...
Biology of Blood and Marrow Transplantation 18 (2), 280-288, 2012
强制性开放获取政策： US National Institutes of Health
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
MM Berrien-Elliott, M Becker-Hapak, AF Cashen, M Jacobs, P Wong, ...
Blood, The Journal of the American Society of Hematology 139 (8), 1177-1183, 2022
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
MM Berrien-Elliott, JA Foltz, DA Russler-Germain, CC Neal, J Tran, ...
Science translational medicine 14 (633), eabm1375, 2022
强制性开放获取政策： US National Institutes of Health
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
MA Schroeder, MP Rettig, S Lopez, S Christ, M Fiala, W Eades, FA Mir, ...
Blood, The Journal of the American Society of Hematology 129 (19), 2680-2692, 2017
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定